Releases

Vanderbilt researchers developed new prognostic models for breast cancer outcomes and found that adding postdiagnostic weight change as a factor improves the prediction. Read More

Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares why it's important for people to get vaccinated, even if they've already had COVID-19. Read More

Fluid build-up in the brain — hydrocephalus — increases pressure and risk for brain damage; Vanderbilt researchers have now identified genes and signaling pathways associated with the condition. Read More

Divisive party politics continue to dominate attitudes among Tennessee residents on key social issues, including the state’s response to COVID-19, willingness to get vaccinated and questions about whether the 2020 presidential election was “stolen,” according to the latest Vanderbilt University poll. Read More

Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year. Read More

A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development. Read More

Vanderbilt University’s annual Giving Day kicked off at midnight, and the entire university community is invited to celebrate this special event. Faculty and staff play a vital role in supporting Vanderbilt’s mission and are encouraged to consider extending their investment in the university by making a gift of any size to an area that is meaningful to them.   Read More

Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.  Read More

Vanderbilt University Medical Center (VUMC) researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease. Read More

Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read More

Twenty-nine prominent faculty from across campus comprise Vanderbilt University’s latest endowed chair honorees. They include scholars working in diverse areas—from election analysis and lung cancer research to the nascent field of neurolaw, exploring the brain mechanism underlying legal decision-making. Read More

Vanderbilt University has announced the University Diversity Council members for 2020-21. Formed last year, the council advocates for equity, diversity and inclusion across all areas of Vanderbilt. Read More

People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered. Read More

Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19. Read More

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.  Read More

Vanderbilt University Medical Center investigators have used high-throughput robotic technology to rapidly study and classify variations in a gene linked to heart rhythm disorders and cardiac conditions. Read More

Vanderbilt University Medical Center scientists have identified a C. diff protein system that senses and captures heme (part of hemoglobin) to build a protective shield that fends off threats from our immune system and antibiotics. Read More

After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio. Read More

The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants. Read More